247 related articles for article (PubMed ID: 8790348)
1. TRAF5, a novel tumor necrosis factor receptor-associated factor family protein, mediates CD40 signaling.
Ishida TK; Tojo T; Aoki T; Kobayashi N; Ohishi T; Watanabe T; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1996 Sep; 93(18):9437-42. PubMed ID: 8790348
[TBL] [Abstract][Full Text] [Related]
2. Identification of TRAF6, a novel tumor necrosis factor receptor-associated factor protein that mediates signaling from an amino-terminal domain of the CD40 cytoplasmic region.
Ishida T; Mizushima Si; Azuma S; Kobayashi N; Tojo T; Suzuki K; Aizawa S; Watanabe T; Mosialos G; Kieff E; Yamamoto T; Inoue J
J Biol Chem; 1996 Nov; 271(46):28745-8. PubMed ID: 8910514
[TBL] [Abstract][Full Text] [Related]
3. Differential requirements for tumor necrosis factor receptor-associated factor family proteins in CD40-mediated induction of NF-kappaB and Jun N-terminal kinase activation.
Leo E; Welsh K; Matsuzawa S; Zapata JM; Kitada S; Mitchell RS; Ely KR; Reed JC
J Biol Chem; 1999 Aug; 274(32):22414-22. PubMed ID: 10428814
[TBL] [Abstract][Full Text] [Related]
4. TRAF5, an activator of NF-kappaB and putative signal transducer for the lymphotoxin-beta receptor.
Nakano H; Oshima H; Chung W; Williams-Abbott L; Ware CF; Yagita H; Okumura K
J Biol Chem; 1996 Jun; 271(25):14661-4. PubMed ID: 8663299
[TBL] [Abstract][Full Text] [Related]
5. CD40-tumor necrosis factor receptor-associated factor (TRAF) interactions: regulation of CD40 signaling through multiple TRAF binding sites and TRAF hetero-oligomerization.
Pullen SS; Miller HG; Everdeen DS; Dang TT; Crute JJ; Kehry MR
Biochemistry; 1998 Aug; 37(34):11836-45. PubMed ID: 9718306
[TBL] [Abstract][Full Text] [Related]
6. Two differently regulated nuclear factor kappaB activation pathways triggered by the cytoplasmic tail of CD40.
Tsukamoto N; Kobayashi N; Azuma S; Yamamoto T; Inoue J
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1234-9. PubMed ID: 9990007
[TBL] [Abstract][Full Text] [Related]
7. Involvement of CRAF1, a relative of TRAF, in CD40 signaling.
Cheng G; Cleary AM; Ye ZS; Hong DI; Lederman S; Baltimore D
Science; 1995 Mar; 267(5203):1494-8. PubMed ID: 7533327
[TBL] [Abstract][Full Text] [Related]
8. Specificities of CD40 signaling: involvement of TRAF2 in CD40-induced NF-kappaB activation and intercellular adhesion molecule-1 up-regulation.
Lee HH; Dempsey PW; Parks TP; Zhu X; Baltimore D; Cheng G
Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1421-6. PubMed ID: 9990039
[TBL] [Abstract][Full Text] [Related]
9. Tumor necrosis factor receptor-associated factor (TRAF) 5 and TRAF2 are involved in CD30-mediated NFkappaB activation.
Aizawa S; Nakano H; Ishida T; Horie R; Nagai M; Ito K; Yagita H; Okumura K; Inoue J; Watanabe T
J Biol Chem; 1997 Jan; 272(4):2042-5. PubMed ID: 8999898
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of a cDNA encoding the human homolog of tumor necrosis factor receptor-associated factor 5 (TRAF5).
Mizushima S; Fujita M; Ishida T; Azuma S; Kato K; Hirai M; Otsuka M; Yamamoto T; Inoue J
Gene; 1998 Jan; 207(2):135-40. PubMed ID: 9511754
[TBL] [Abstract][Full Text] [Related]
11. TRAF3 forms heterotrimers with TRAF2 and modulates its ability to mediate NF-{kappa}B activation.
He L; Grammer AC; Wu X; Lipsky PE
J Biol Chem; 2004 Dec; 279(53):55855-65. PubMed ID: 15383523
[TBL] [Abstract][Full Text] [Related]
12. TTRAP, a novel protein that associates with CD40, tumor necrosis factor (TNF) receptor-75 and TNF receptor-associated factors (TRAFs), and that inhibits nuclear factor-kappa B activation.
Pype S; Declercq W; Ibrahimi A; Michiels C; Van Rietschoten JG; Dewulf N; de Boer M; Vandenabeele P; Huylebroeck D; Remacle JE
J Biol Chem; 2000 Jun; 275(24):18586-93. PubMed ID: 10764746
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor receptor-associated factor 6 (TRAF6) stimulates extracellular signal-regulated kinase (ERK) activity in CD40 signaling along a ras-independent pathway.
Kashiwada M; Shirakata Y; Inoue JI; Nakano H; Okazaki K; Okumura K; Yamamoto T; Nagaoka H; Takemori T
J Exp Med; 1998 Jan; 187(2):237-44. PubMed ID: 9432981
[TBL] [Abstract][Full Text] [Related]
14. Characterization of CD40 signaling determinants regulating nuclear factor-kappa B activation in B lymphocytes.
Hsing Y; Hostager BS; Bishop GA
J Immunol; 1997 Nov; 159(10):4898-906. PubMed ID: 9366415
[TBL] [Abstract][Full Text] [Related]
15. TRAF2-mediated activation of NF-kappa B by TNF receptor 2 and CD40.
Rothe M; Sarma V; Dixit VM; Goeddel DV
Science; 1995 Sep; 269(5229):1424-7. PubMed ID: 7544915
[TBL] [Abstract][Full Text] [Related]
16. TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40.
Kraus ZJ; Nakano H; Bishop GA
Proc Natl Acad Sci U S A; 2009 Oct; 106(40):17140-5. PubMed ID: 19805155
[TBL] [Abstract][Full Text] [Related]
17. Cellular responses to murine CD40 in a mouse B cell line may be TRAF dependent or independent.
Manning E; Pullen SS; Souza DJ; Kehry M; Noelle RJ
Eur J Immunol; 2002 Jan; 32(1):39-49. PubMed ID: 11754002
[TBL] [Abstract][Full Text] [Related]
18. A novel RING finger protein interacts with the cytoplasmic domain of CD40.
Hu HM; O'Rourke K; Boguski MS; Dixit VM
J Biol Chem; 1994 Dec; 269(48):30069-72. PubMed ID: 7527023
[TBL] [Abstract][Full Text] [Related]
19. Targeted disruption of Traf5 gene causes defects in CD40- and CD27-mediated lymphocyte activation.
Nakano H; Sakon S; Koseki H; Takemori T; Tada K; Matsumoto M; Munechika E; Sakai T; Shirasawa T; Akiba H; Kobata T; Santee SM; Ware CF; Rennert PD; Taniguchi M; Yagita H; Okumura K
Proc Natl Acad Sci U S A; 1999 Aug; 96(17):9803-8. PubMed ID: 10449775
[TBL] [Abstract][Full Text] [Related]
20. Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3.
Sandberg M; Hammerschmidt W; Sugden B
J Virol; 1997 Jun; 71(6):4649-56. PubMed ID: 9151858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
